Catalyst Funds Management Pty LTD Dynavax Technologies Corp Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 8,800 shares of DVAX stock, worth $113,080. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,800Holding current value
$113,080% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
276Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$281 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$161 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$118 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$107 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$98.8 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.63B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...